Literature DB >> 19799453

In vitro evaluation of functional interaction of integrin alphavbeta3 and matrix metalloprotease-2.

Deepali G Vartak1, Bao-Shiang Lee, Richard A Gemeinhart.   

Abstract

Integrin alphavbeta3 and matrix metalloprotease-2 (MMP-2) are two established molecular targets of angiogenesis. Basic understanding of various forms of functional interaction of integrin alphavbeta3 and active MMP-2 may be used to develop therapeutic approaches. Based upon the idea that integrins are present on the surface of invasive cells and MMP-2 may be localized to this and other cell-surface receptors, we investigated the hypothesis that integrin binding will alter cleavage of MMP-2 substrates. To investigate this hypothesis, integrin-binding and MMP-2 cleavable motifs were combined in a single peptide, MMP-RGD, designed with fluorescent probes for monitoring peptide cleavage. MMP-RGD was bound to integrin alphavbeta3 with equal affinity compared to the integrin-binding motif and was cleaved with equal specificity by active MMP-2. MMP-RGD bound to human umbilical vein endothelial cells (HUVECs). MMP-2 from HUVECs cleaved MMP-RGD, but the cleavage was not altered due to integrin binding. Our results indicate that integrin alphavbeta3 and active MMP-2 may not be as functionally collaborative for substrate cleavage as expected based on the current knowledge of their cell surface colocalization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19799453      PMCID: PMC2790922          DOI: 10.1021/mp900152t

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  48 in total

1.  Design and therapeutic application of matrix metalloproteinase inhibitors.

Authors:  M Whittaker; C D Floyd; P Brown; A J Gearing
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

Review 2.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

3.  A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.

Authors:  V W Engleman; G A Nickols; F P Ross; M A Horton; D W Griggs; S L Settle; P G Ruminski; S L Teitelbaum
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

4.  In vivo imaging of integrin alpha v beta 3 expression using fluorescence-mediated tomography.

Authors:  Angelika von Wallbrunn; Carsten Höltke; Michael Zühlsdorf; Walter Heindel; Michael Schäfers; Christoph Bremer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-28       Impact factor: 9.236

Review 5.  Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.

Authors:  Shuang Liu
Journal:  Mol Pharm       Date:  2006 Sep-Oct       Impact factor: 4.939

6.  The involvement of the fibronectin type II-like modules of human gelatinase A in cell surface localization and activation.

Authors:  B Steffensen; H F Bigg; C M Overall
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

Review 7.  Integrins in angiogenesis and lymphangiogenesis.

Authors:  Christie J Avraamides; Barbara Garmy-Susini; Judith A Varner
Journal:  Nat Rev Cancer       Date:  2008-05-22       Impact factor: 60.716

8.  Requirement of vascular integrin alpha v beta 3 for angiogenesis.

Authors:  P C Brooks; R A Clark; D A Cheresh
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

9.  Continuous real-time measurement of tumor necrosis factor-alpha converting enzyme activity on live cells.

Authors:  Montserrat Alvarez-Iglesias; Gareth Wayne; Kieran P O'Dea; Augustin Amour; Masao Takata
Journal:  Lab Invest       Date:  2005-11       Impact factor: 5.662

10.  Matrix metalloproteinase-2 activation modulates glioma cell migration.

Authors:  E I Deryugina; M A Bourdon; G X Luo; R A Reisfeld; A Strongin
Journal:  J Cell Sci       Date:  1997-10       Impact factor: 5.285

View more
  4 in total

1.  Effects of molecular weight and loading on matrix metalloproteinase-2 mediated release from poly(ethylene glycol) diacrylate hydrogels.

Authors:  Amy E Ross; Mary Y Tang; Richard A Gemeinhart
Journal:  AAPS J       Date:  2012-04-26       Impact factor: 4.009

2.  Improving matrix metalloproteinase-2 specific response of a hydrogel system using electrophoresis.

Authors:  Yu Zhang; Richard A Gemeinhart
Journal:  Int J Pharm       Date:  2012-03-13       Impact factor: 5.875

3.  In-house preparation of hydrogels for batch affinity purification of glutathione S-transferase tagged recombinant proteins.

Authors:  Jason S Buhrman; Jamie E Rayahin; Melanie Köllmer; Richard A Gemeinhart
Journal:  BMC Biotechnol       Date:  2012-09-18       Impact factor: 2.563

4.  Dual targeting of integrin αvβ3 and matrix metalloproteinase-2 for optical imaging of tumors and chemotherapeutic delivery.

Authors:  Jessica L Crisp; Elamprakash N Savariar; Heather L Glasgow; Lesley G Ellies; Michael A Whitney; Roger Y Tsien
Journal:  Mol Cancer Ther       Date:  2014-04-15       Impact factor: 6.261

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.